Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer

Laryngoscope

Volumn 119, Issue 11, 2009, Pages 2150-2155

  Gourin, Christine G ^a   Boyce, Brian J ^b   Williams, Hadyn T ^b   Herdman, Anne V ^c   Bilodeau, Paul A ^b   Coleman, Teresa A ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c Erlanger Medical Center   (United States)

Author keywords

Head and neck neoplasms; Neck dissection; Nodal metastases; Positron emission tomography computed tomography; Squamous cell cancer; Treatment

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE; MALE; MEDICAL RECORD REVIEW; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; TREATMENT RESPONSE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73449130212     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20523     Document Type: Article

References (33)

1. Mendenhall WM, Million RR, Cassisi NJ. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 1986;12: 733-740.
2. Mendenhall WM, Parsons JT, Amdur RJ, Cassisi NJ, Million RR. Squamous cell carcinoma of the head and neck treated with radiotherapy: does planned neck dissection reduce the chance for successful surgical management of subsequent local recurrence? Head Neck Surg 1988;10:302-304.
3. Nouraei SA, Upile T, Al-Yaghchi C, et al. Role of planned postchemoradiotherapy selective neck dissection in the multimodality management of head and neck cancer. Laryngoscope 2008;118:797-803.
4. McHamm SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791-798.
5. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-455.
6. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997;19:559-566.
7. Clayman GL, Johnson CJ II, Morrison W, Ginsberg L, Lippman SM. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 2001;127:135-139.
8. Grabenbauer GG, Rodel C, Ernst-Stecken A, et al. Neck dissection following radiochemotherapy of advanced head and neck cancer - for selected cases only? Radiother Oncol 2003;66:57-63.
9. Nayak JV, Walvekar RR, Andrade RS, et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 2007;117:2129-2134.
10. Lau H, Phan T, Mackinnon J, Matthews TW. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2008;134:257-261.
11. Peters LJ, Weber RS, Morrison WH, et al. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 1996;18:552-559.
12. Ong SC, Schoder H, Lee NY, et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008;49:532-540.
13. Schoder H, Yeung HWD, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231:65-72.
14. Stensen KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy. Arch Otol Head Neck Surg 2000;126:950-956.
15. Frank DK, Hu KS, Culliney BE, et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 2005;115:1015-1020.
16. Lavertu P, Adelstein DJ, Saxton JP, et al. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:142-148.
17. Lavertu P, Bonafide JP, Adelstein DA, et al. Comparison of surgical complications after organ-preserving therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401-406.
18. Gourin CG, Williams HT, Seabolt WN, et al. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 2006;116:705-710.
19. Lonneux M, Lawson G, Idel C, et al. Positron emission tomography with flourodeoxyglucose for suspected head and neck recurrence in the symptomatic patient. Laryngoscope 2000;110:1493-1497.
20. Ryan WR, Fee WE Jr, Le QT, Pinto HA. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 2005;115:645-650.
21. Fischbein NJ, Assar SA, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol 1998;19:1189-1196.
22. Sakamoto H, Nakai Y, Ohashi Y, et al. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas. Acta Otolaryngol Suppl 1998;538:254-260.
23. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head and neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiation Biol Phys 2004:58:694-697.
24. Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 2000;18:651-658.
25. Greven KM, Williams DW III, McGuirt WF Sr, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 2001;23:942-946.
26. Conessa C, Herve S, Foehrenbach H, Poncet JL. FDG-PET scan in local follow up of irradiated head and neck squamous cell carcinomas. Ann Otol Rhinol Laryngol 2004; 113:628-635.
27. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005;27:175-181.
28. Tan A, Adelstein DJ, Rybicki LA, et al. Ability of positron emission tomography to detect residual node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2007;133:435-440.
29. Yao M, Graham MM, Hoffman HT, et al. The role of postradiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head and neck squamous cell carcinoma. Int J Radiation Biol Phys 2004;59:1001-1010.
30. Yao M, Luo P, Hoffman HT, et al. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment. Am J Clin Oncol 2007;30:264-270.
31. Vedrine PO, Thariat J, Hitier M, et al. Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group. Laryngoscope 2008;118:1775-1780.
32. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418-1423.
33. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008;26:3582-3589.